Epigenetics Drugs and Diagnostic Technologies Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Epigenetics Drugs and Diagnostic Technologies Market to 2027 - Global Analysis and Forecasts By Product (Reagents, Kits, Instruments, Enzymes, Services,); Technology (DNA Methylation, Histone Methylation, Histone Acetylation, Large Non-coding RNA, MicroRNA Modification, Chromatin Structures,); Type (Histone Deacetylase (HDAC) Inhibitors, DNA Methyltransferase (DNMT) Inhibitors,); Application (Oncology, Non-oncology)

Report Code: TIPRE00005164 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
MARKET INTRODUCTION
Epigenetics is a study of change in gene expression in a phenotype without changing the genotype. Epigenetics drugs and diagnostics are used while screening early stage cancer and other abnormal changes in skin cells, liver cells, brain cells and others.

MARKET DYNAMICS
The Epigenetics Drugs and Diagnostic Technologies market is anticipated to grow in the forecast, owing to the factors such as growing geriatric population, rise in oncology and non-oncology disorders, rising prevalence of cancer, technological advancements, low cost and time needed and increasing funding for research and development.

MARKET SCOPE
The "Global Epigenetics Drugs and Diagnostic Technologies Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of Epigenetics Drugs and Diagnostic Technologies market with detailed market segmentation by Product, Technology, Type, Application and geography. The global Epigenetics Drugs and Diagnostic Technologies market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Epigenetics Drugs and Diagnostic Technologies market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global Epigenetics Drugs and Diagnostic Technologies market is segmented on the basis of Type, Technology, Product and Application. Based on Type the market is segmented into Histone Deacetylase (HDAC) Inhibitors, DNA Methyltransferase (DNMT) Inhibitors. Based on Technology the market is segmented into DNA Methylation, Histone Methylation, Histone Acetylation, Large Non-coding RNA, MicroRNA Modification, Chromatin Structures. Based on Product the market is segmented into Reagents, Kits, Instruments, Enzymes, Services. Based on Application the market is segmented into Oncology, NON-oncology.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Epigenetics Drugs and Diagnostic Technologies market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Epigenetics Drugs and Diagnostic Technologies market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Epigenetics Drugs and Diagnostic Technologies market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Epigenetics Drugs and Diagnostic Technologies market in these regions.
MARKET PLAYERS
The reports cover key developments in the Epigenetics Drugs and Diagnostic Technologies market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Epigenetics Drugs and Diagnostic Technologies market are anticipated to lucrative growth opportunities in the future with the rising demand for Epigenetics Drugs and Diagnostic Technologies market in the global market. Below mentioned is the list of few companies engaged in the Epigenetics Drugs and Diagnostic Technologies market.

The report also includes the profiles of Epigenetics Drugs and Diagnostic Technologies market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  •  Roche Diagnostics
  •  Thermo Fisher Scientific, Inc
  •  Eisai Co. Ltd
  •  Novartis AG
  •  Illumina, Inc
  •  QIAGEN
  •  Abcam PLC
  •  Merck KGaA.
  •  Genome Profiling, LLC
  •  HistoGeneX N.V

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Epigenetics Drugs And Diagnostics Technologies Market - By Product
1.3.2 Epigenetics Drugs And Diagnostics Technologies Market - By Technology
1.3.3 Epigenetics Drugs And Diagnostics Technologies Market - By Type
1.3.4 Epigenetics Drugs And Diagnostics Technologies Market - By Application
1.3.5 Epigenetics Drugs And Diagnostics Technologies Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. EPIGENETICS DRUGS AND DIAGNOSTICS TECHNOLOGIES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. EPIGENETICS DRUGS AND DIAGNOSTICS TECHNOLOGIES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. EPIGENETICS DRUGS AND DIAGNOSTICS TECHNOLOGIES MARKET - GLOBAL MARKET ANALYSIS
6.1. EPIGENETICS DRUGS AND DIAGNOSTICS TECHNOLOGIES - GLOBAL MARKET OVERVIEW
6.2. EPIGENETICS DRUGS AND DIAGNOSTICS TECHNOLOGIES - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. EPIGENETICS DRUGS AND DIAGNOSTICS TECHNOLOGIES MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. REAGENTS
7.3.1. Overview
7.3.2. Reagents Market Forecast and Analysis
7.4. KITS
7.4.1. Overview
7.4.2. Kits Market Forecast and Analysis
7.4.3. Chip Sequencing Kit Market
7.4.3.1. Overview
7.4.3.2. Chip Sequencing Kit Market Forecast and Analysis
7.4.4. Whole Genomic Amplification Kit Market
7.4.4.1. Overview
7.4.4.2. Whole Genomic Amplification Kit Market Forecast and Analysis
7.4.5. Bisulfite Conversion Kit Market
7.4.5.1. Overview
7.4.5.2. Bisulfite Conversion Kit Market Forecast and Analysis
7.4.6. RNA Sequencing Kit Market
7.4.6.1. Overview
7.4.6.2. RNA Sequencing Kit Market Forecast and Analysis
7.4.7. Others Market
7.4.7.1. Overview
7.4.7.2. Others Market Forecast and Analysis
7.5. INSTRUMENTS
7.5.1. Overview
7.5.2. Instruments Market Forecast and Analysis
7.6. ENZYMES
7.6.1. Overview
7.6.2. Enzymes Market Forecast and Analysis
7.7. SERVICES
7.7.1. Overview
7.7.2. Services Market Forecast and Analysis
7.8.
7.8.1. Overview
7.8.2. Market Forecast and Analysis
8. EPIGENETICS DRUGS AND DIAGNOSTICS TECHNOLOGIES MARKET - REVENUE AND FORECASTS TO 2027 - TECHNOLOGY
8.1. OVERVIEW
8.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
8.3. DNA METHYLATION
8.3.1. Overview
8.3.2. DNA Methylation Market Forecast and Analysis
8.4. HISTONE METHYLATION
8.4.1. Overview
8.4.2. Histone Methylation Market Forecast and Analysis
8.5. HISTONE ACETYLATION
8.5.1. Overview
8.5.2. Histone Acetylation Market Forecast and Analysis
8.6. LARGE NON-CODING RNA
8.6.1. Overview
8.6.2. Large Non-coding RNA Market Forecast and Analysis
8.7. MICRORNA MODIFICATION
8.7.1. Overview
8.7.2. MicroRNA Modification Market Forecast and Analysis
8.8. CHROMATIN STRUCTURES
8.8.1. Overview
8.8.2. Chromatin Structures Market Forecast and Analysis
8.9.
8.9.1. Overview
8.9.2. Market Forecast and Analysis
9. EPIGENETICS DRUGS AND DIAGNOSTICS TECHNOLOGIES MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
9.1. OVERVIEW
9.2. TYPE MARKET FORECASTS AND ANALYSIS
9.3. HISTONE DEACETYLASE (HDAC) INHIBITORS
9.3.1. Overview
9.3.2. Histone Deacetylase (HDAC) Inhibitors Market Forecast and Analysis
9.4. DNA METHYLTRANSFERASE (DNMT) INHIBITORS
9.4.1. Overview
9.4.2. DNA Methyltransferase (DNMT) Inhibitors Market Forecast and Analysis
9.5.
9.5.1. Overview
9.5.2. Market Forecast and Analysis
10. EPIGENETICS DRUGS AND DIAGNOSTICS TECHNOLOGIES MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
10.1. OVERVIEW
10.2. APPLICATION MARKET FORECASTS AND ANALYSIS
10.3. ONCOLOGY
10.3.1. Overview
10.3.2. Oncology Market Forecast and Analysis
10.3.3. Solid Tumors Market
10.3.3.1. Overview
10.3.3.2. Solid Tumors Market Forecast and Analysis
10.3.4. Liquid Tumor Market
10.3.4.1. Overview
10.3.4.2. Liquid Tumor Market Forecast and Analysis
10.4. NON-ONCOLOGY
10.4.1. Overview
10.4.2. Non-oncology Market Forecast and Analysis
10.4.3. Inflammatory Diseases Market
10.4.3.1. Overview
10.4.3.2. Inflammatory Diseases Market Forecast and Analysis
10.4.4. Metabolic Diseases Market
10.4.4.1. Overview
10.4.4.2. Metabolic Diseases Market Forecast and Analysis
10.4.5. Infectious Diseases Market
10.4.5.1. Overview
10.4.5.2. Infectious Diseases Market Forecast and Analysis
10.4.6. Cardiovascular Diseases Market
10.4.6.1. Overview
10.4.6.2. Cardiovascular Diseases Market Forecast and Analysis
10.4.7. Others Market
10.4.7.1. Overview
10.4.7.2. Others Market Forecast and Analysis
11. EPIGENETICS DRUGS AND DIAGNOSTICS TECHNOLOGIES MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Epigenetics Drugs And Diagnostics Technologies Market Overview
11.1.2 North America Epigenetics Drugs And Diagnostics Technologies Market Forecasts and Analysis
11.1.3 North America Epigenetics Drugs And Diagnostics Technologies Market Forecasts and Analysis - By Product
11.1.4 North America Epigenetics Drugs And Diagnostics Technologies Market Forecasts and Analysis - By Technology
11.1.5 North America Epigenetics Drugs And Diagnostics Technologies Market Forecasts and Analysis - By Type
11.1.6 North America Epigenetics Drugs And Diagnostics Technologies Market Forecasts and Analysis - By Application
11.1.7 North America Epigenetics Drugs And Diagnostics Technologies Market Forecasts and Analysis - By Countries
11.1.7.1 United States Epigenetics Drugs And Diagnostics Technologies Market
11.1.7.1.1 United States Epigenetics Drugs And Diagnostics Technologies Market by Product
11.1.7.1.2 United States Epigenetics Drugs And Diagnostics Technologies Market by Technology
11.1.7.1.3 United States Epigenetics Drugs And Diagnostics Technologies Market by Type
11.1.7.1.4 United States Epigenetics Drugs And Diagnostics Technologies Market by Application
11.1.7.2 Canada Epigenetics Drugs And Diagnostics Technologies Market
11.1.7.2.1 Canada Epigenetics Drugs And Diagnostics Technologies Market by Product
11.1.7.2.2 Canada Epigenetics Drugs And Diagnostics Technologies Market by Technology
11.1.7.2.3 Canada Epigenetics Drugs And Diagnostics Technologies Market by Type
11.1.7.2.4 Canada Epigenetics Drugs And Diagnostics Technologies Market by Application
11.1.7.3 Mexico Epigenetics Drugs And Diagnostics Technologies Market
11.1.7.3.1 Mexico Epigenetics Drugs And Diagnostics Technologies Market by Product
11.1.7.3.2 Mexico Epigenetics Drugs And Diagnostics Technologies Market by Technology
11.1.7.3.3 Mexico Epigenetics Drugs And Diagnostics Technologies Market by Type
11.1.7.3.4 Mexico Epigenetics Drugs And Diagnostics Technologies Market by Application
11.2. EUROPE
11.2.1 Europe Epigenetics Drugs And Diagnostics Technologies Market Overview
11.2.2 Europe Epigenetics Drugs And Diagnostics Technologies Market Forecasts and Analysis
11.2.3 Europe Epigenetics Drugs And Diagnostics Technologies Market Forecasts and Analysis - By Product
11.2.4 Europe Epigenetics Drugs And Diagnostics Technologies Market Forecasts and Analysis - By Technology
11.2.5 Europe Epigenetics Drugs And Diagnostics Technologies Market Forecasts and Analysis - By Type
11.2.6 Europe Epigenetics Drugs And Diagnostics Technologies Market Forecasts and Analysis - By Application
11.2.7 Europe Epigenetics Drugs And Diagnostics Technologies Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Epigenetics Drugs And Diagnostics Technologies Market
11.2.7.1.1 Germany Epigenetics Drugs And Diagnostics Technologies Market by Product
11.2.7.1.2 Germany Epigenetics Drugs And Diagnostics Technologies Market by Technology
11.2.7.1.3 Germany Epigenetics Drugs And Diagnostics Technologies Market by Type
11.2.7.1.4 Germany Epigenetics Drugs And Diagnostics Technologies Market by Application
11.2.7.2 France Epigenetics Drugs And Diagnostics Technologies Market
11.2.7.2.1 France Epigenetics Drugs And Diagnostics Technologies Market by Product
11.2.7.2.2 France Epigenetics Drugs And Diagnostics Technologies Market by Technology
11.2.7.2.3 France Epigenetics Drugs And Diagnostics Technologies Market by Type
11.2.7.2.4 France Epigenetics Drugs And Diagnostics Technologies Market by Application
11.2.7.3 Italy Epigenetics Drugs And Diagnostics Technologies Market
11.2.7.3.1 Italy Epigenetics Drugs And Diagnostics Technologies Market by Product
11.2.7.3.2 Italy Epigenetics Drugs And Diagnostics Technologies Market by Technology
11.2.7.3.3 Italy Epigenetics Drugs And Diagnostics Technologies Market by Type
11.2.7.3.4 Italy Epigenetics Drugs And Diagnostics Technologies Market by Application
11.2.7.4 Spain Epigenetics Drugs And Diagnostics Technologies Market
11.2.7.4.1 Spain Epigenetics Drugs And Diagnostics Technologies Market by Product
11.2.7.4.2 Spain Epigenetics Drugs And Diagnostics Technologies Market by Technology
11.2.7.4.3 Spain Epigenetics Drugs And Diagnostics Technologies Market by Type
11.2.7.4.4 Spain Epigenetics Drugs And Diagnostics Technologies Market by Application
11.2.7.5 United Kingdom Epigenetics Drugs And Diagnostics Technologies Market
11.2.7.5.1 United Kingdom Epigenetics Drugs And Diagnostics Technologies Market by Product
11.2.7.5.2 United Kingdom Epigenetics Drugs And Diagnostics Technologies Market by Technology
11.2.7.5.3 United Kingdom Epigenetics Drugs And Diagnostics Technologies Market by Type
11.2.7.5.4 United Kingdom Epigenetics Drugs And Diagnostics Technologies Market by Application
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Epigenetics Drugs And Diagnostics Technologies Market Overview
11.3.2 Asia-Pacific Epigenetics Drugs And Diagnostics Technologies Market Forecasts and Analysis
11.3.3 Asia-Pacific Epigenetics Drugs And Diagnostics Technologies Market Forecasts and Analysis - By Product
11.3.4 Asia-Pacific Epigenetics Drugs And Diagnostics Technologies Market Forecasts and Analysis - By Technology
11.3.5 Asia-Pacific Epigenetics Drugs And Diagnostics Technologies Market Forecasts and Analysis - By Type
11.3.6 Asia-Pacific Epigenetics Drugs And Diagnostics Technologies Market Forecasts and Analysis - By Application
11.3.7 Asia-Pacific Epigenetics Drugs And Diagnostics Technologies Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Epigenetics Drugs And Diagnostics Technologies Market
11.3.7.1.1 Australia Epigenetics Drugs And Diagnostics Technologies Market by Product
11.3.7.1.2 Australia Epigenetics Drugs And Diagnostics Technologies Market by Technology
11.3.7.1.3 Australia Epigenetics Drugs And Diagnostics Technologies Market by Type
11.3.7.1.4 Australia Epigenetics Drugs And Diagnostics Technologies Market by Application
11.3.7.2 China Epigenetics Drugs And Diagnostics Technologies Market
11.3.7.2.1 China Epigenetics Drugs And Diagnostics Technologies Market by Product
11.3.7.2.2 China Epigenetics Drugs And Diagnostics Technologies Market by Technology
11.3.7.2.3 China Epigenetics Drugs And Diagnostics Technologies Market by Type
11.3.7.2.4 China Epigenetics Drugs And Diagnostics Technologies Market by Application
11.3.7.3 India Epigenetics Drugs And Diagnostics Technologies Market
11.3.7.3.1 India Epigenetics Drugs And Diagnostics Technologies Market by Product
11.3.7.3.2 India Epigenetics Drugs And Diagnostics Technologies Market by Technology
11.3.7.3.3 India Epigenetics Drugs And Diagnostics Technologies Market by Type
11.3.7.3.4 India Epigenetics Drugs And Diagnostics Technologies Market by Application
11.3.7.4 Japan Epigenetics Drugs And Diagnostics Technologies Market
11.3.7.4.1 Japan Epigenetics Drugs And Diagnostics Technologies Market by Product
11.3.7.4.2 Japan Epigenetics Drugs And Diagnostics Technologies Market by Technology
11.3.7.4.3 Japan Epigenetics Drugs And Diagnostics Technologies Market by Type
11.3.7.4.4 Japan Epigenetics Drugs And Diagnostics Technologies Market by Application
11.3.7.5 South Korea Epigenetics Drugs And Diagnostics Technologies Market
11.3.7.5.1 South Korea Epigenetics Drugs And Diagnostics Technologies Market by Product
11.3.7.5.2 South Korea Epigenetics Drugs And Diagnostics Technologies Market by Technology
11.3.7.5.3 South Korea Epigenetics Drugs And Diagnostics Technologies Market by Type
11.3.7.5.4 South Korea Epigenetics Drugs And Diagnostics Technologies Market by Application
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Epigenetics Drugs And Diagnostics Technologies Market Overview
11.4.2 Middle East and Africa Epigenetics Drugs And Diagnostics Technologies Market Forecasts and Analysis
11.4.3 Middle East and Africa Epigenetics Drugs And Diagnostics Technologies Market Forecasts and Analysis - By Product
11.4.4 Middle East and Africa Epigenetics Drugs And Diagnostics Technologies Market Forecasts and Analysis - By Technology
11.4.5 Middle East and Africa Epigenetics Drugs And Diagnostics Technologies Market Forecasts and Analysis - By Type
11.4.6 Middle East and Africa Epigenetics Drugs And Diagnostics Technologies Market Forecasts and Analysis - By Application
11.4.7 Middle East and Africa Epigenetics Drugs And Diagnostics Technologies Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Epigenetics Drugs And Diagnostics Technologies Market
11.4.7.1.1 South Africa Epigenetics Drugs And Diagnostics Technologies Market by Product
11.4.7.1.2 South Africa Epigenetics Drugs And Diagnostics Technologies Market by Technology
11.4.7.1.3 South Africa Epigenetics Drugs And Diagnostics Technologies Market by Type
11.4.7.1.4 South Africa Epigenetics Drugs And Diagnostics Technologies Market by Application
11.4.7.2 Saudi Arabia Epigenetics Drugs And Diagnostics Technologies Market
11.4.7.2.1 Saudi Arabia Epigenetics Drugs And Diagnostics Technologies Market by Product
11.4.7.2.2 Saudi Arabia Epigenetics Drugs And Diagnostics Technologies Market by Technology
11.4.7.2.3 Saudi Arabia Epigenetics Drugs And Diagnostics Technologies Market by Type
11.4.7.2.4 Saudi Arabia Epigenetics Drugs And Diagnostics Technologies Market by Application
11.4.7.3 U.A.E Epigenetics Drugs And Diagnostics Technologies Market
11.4.7.3.1 U.A.E Epigenetics Drugs And Diagnostics Technologies Market by Product
11.4.7.3.2 U.A.E Epigenetics Drugs And Diagnostics Technologies Market by Technology
11.4.7.3.3 U.A.E Epigenetics Drugs And Diagnostics Technologies Market by Type
11.4.7.3.4 U.A.E Epigenetics Drugs And Diagnostics Technologies Market by Application
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Epigenetics Drugs And Diagnostics Technologies Market Overview
11.5.2 South and Central America Epigenetics Drugs And Diagnostics Technologies Market Forecasts and Analysis
11.5.3 South and Central America Epigenetics Drugs And Diagnostics Technologies Market Forecasts and Analysis - By Product
11.5.4 South and Central America Epigenetics Drugs And Diagnostics Technologies Market Forecasts and Analysis - By Technology
11.5.5 South and Central America Epigenetics Drugs And Diagnostics Technologies Market Forecasts and Analysis - By Type
11.5.6 South and Central America Epigenetics Drugs And Diagnostics Technologies Market Forecasts and Analysis - By Application
11.5.7 South and Central America Epigenetics Drugs And Diagnostics Technologies Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Epigenetics Drugs And Diagnostics Technologies Market
11.5.7.1.1 Brazil Epigenetics Drugs And Diagnostics Technologies Market by Product
11.5.7.1.2 Brazil Epigenetics Drugs And Diagnostics Technologies Market by Technology
11.5.7.1.3 Brazil Epigenetics Drugs And Diagnostics Technologies Market by Type
11.5.7.1.4 Brazil Epigenetics Drugs And Diagnostics Technologies Market by Application
11.5.7.2 Argentina Epigenetics Drugs And Diagnostics Technologies Market
11.5.7.2.1 Argentina Epigenetics Drugs And Diagnostics Technologies Market by Product
11.5.7.2.2 Argentina Epigenetics Drugs And Diagnostics Technologies Market by Technology
11.5.7.2.3 Argentina Epigenetics Drugs And Diagnostics Technologies Market by Type
11.5.7.2.4 Argentina Epigenetics Drugs And Diagnostics Technologies Market by Application
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. EPIGENETICS DRUGS AND DIAGNOSTICS TECHNOLOGIES MARKET, KEY COMPANY PROFILES
13.1. ROCHE DIAGNOSTICS
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. THERMO FISHER SCIENTIFIC, INC
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. EISAI CO. LTD
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. NOVARTIS AG
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. ILLUMINA, INC
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. QIAGEN
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. ABCAM PLC
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. MERCK KGAA
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. GENOME PROFILING, LLC
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. HISTOGENEX N.V
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies
  1.  Roche Diagnostics
  2.  Thermo Fisher Scientific, Inc
  3.  Eisai Co. Ltd
  4.  Novartis AG
  5.  Illumina, Inc
  6.  QIAGEN
  7.  Abcam PLC
  8.  Merck KGaA.
  9.  Genome Profiling, LLC
  10.  HistoGeneX N.V